Bioresorbable Scaffolds: Current Evidence and Ongoing Clinical Trials


Bioresorbable scaffolds (BRS) represent a novel approach in coronary stent technology. In contrast to the metallic stents, they provide transient scaffolding, thereby safeguarding early vessel patency and acute gain. Subsequently a process of "decomposition" occurs, that results in the complete absorption of the scaffold. This reduces the risk of late… (More)
DOI: 10.1007/s11886-012-0295-5


1 Figure or Table